Exicure, Inc. (XCUR)
Exicure, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Exicure, Inc. (XCUR) is a Biotechnology company based in US with a market capitalization of $11.2M. Free cash flow was negative at -$8.6M. This page tracks XCUR's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 7 employees · IPO May 22, 2018
Valuation
Valuation & price
$2.81as of May 25, 2026· -63.5% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
2.86
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$11.2M
Market cap
—
Revenue growth (YoY)
100.0%
Gross margin
-$8.6M
Free cash flow (USD)
-$3.6M
Net debt
Net cash position
3.2%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2024
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: May 29, 2026 (EPS $-0.29)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is Exicure, Inc.'s market cap?
Exicure, Inc. (XCUR) has a market capitalization of $11.2M.
What is XCUR's P/E ratio?
A meaningful P/E ratio is not available for XCUR — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is XCUR's price-to-book (P/B) ratio?
XCUR trades at 2.86 times book value per share.
When did Exicure, Inc. last report earnings?
XCUR last reported earnings on May 29, 2026; the next date is not yet scheduled.
Are insiders buying XCUR stock?
SEC Form 4 filings show no open-market insider buys at Exicure, Inc. in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.